Atrium Therapeutics (RNA) Stock Price & Financial Analysis
Atrium Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Atrium Therapeutics
What is the current stock price for RNA?
As of the latest trading session, RNA stock trades at $11.91. The 52-week range is $11.40–$73.06, with a day range of $11.78–$12.14.
What is the P/E ratio for RNA?
The P/E ratio (Price-to-Earnings) for RNA is shown in the Key Statistics section. This valuation metric helps compare Atrium Therapeutics, Inc. to industry peers.
Does RNA pay dividends?
Atrium Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for RNA?
Analyst ratings and recommendations for RNA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of RNA?
Atrium Therapeutics's market capitalization is $203.7M, classifying it as a micro-cap company. Atrium Therapeutics operates in the Healthcare sector within the Biotechnology industry.